
Motley Fool Money
Motley Fool Money is a daily podcast for stock investors.Weekday episodes offer a long-term perspective on business news with The Motley Fool's investment analysts. Weekend shows are a mix of investing classes and longer-form interviews.The show is hosted by Dylan Lewis, Ricky Mulvey, and Mary Long.
Latest episodes

36 snips
Mar 12, 2025 • 33min
Fear, Greed, and Quiet Exuberance
David Meier, an investment analyst known for tracking market trends, and Mark Dixon, CEO of IWG, a leader in hybrid work solutions, dive into the shifting dynamics of work and investment. They discuss how companies have evolved since the pandemic, the implications of recent inflation data, and Meta's ambitious AI chip strategy. Dixon shares insights on adapting office spaces to meet hybrid demands and how businesses can quantify the benefits of in-person collaboration. Their conversation reveals the intersection of technology, finance, and the future of work.

50 snips
Mar 11, 2025 • 29min
Should Investors Prepare for a Recession?
Asit Sharma, an investment analyst at The Motley Fool, and Alison Southwick, a financial expert focused on Social Security issues, dive into critical investment strategies. They discuss the recent tech stock sell-off and the shifting narrative around Tesla’s value amid market pressures. Additionally, they address the new revenue strategies at Southwest Airlines and how these may affect customer loyalty. Lastly, they highlight the funding challenges facing Social Security and offer insightful strategies for incorporating it into retirement planning.

61 snips
Mar 10, 2025 • 32min
Redfin is “Under Contract”
Tim Beyers, a Motley Fool analyst, discusses Rocket Companies' strategic all-stock acquisition of Redfin, aiming to simplify homebuying. He also highlights ServiceNow's $2.8 billion purchase of Moveworks, positioning itself in the AI landscape. Anthony Schiavone shares insights on Vail Resorts, shedding light on the challenges faced due to a ski patrol strike and its declining reputation. They explore Vail's financial strategies and complexity in balancing real estate operations with ski resort management.

67 snips
Mar 8, 2025 • 32min
Marc Benioff on Agentic AI and Salesforce’s Next Chapter
Marc Benioff, founder and CEO of Salesforce, shares his insights on the future of AI and the company's strategic direction. He explains why Salesforce won't hire software engineers this year and reflects on lessons from acquisitions like Slack and Tableau. The conversation touches on the rise of agentic AI, its impact on digital labor, and how technology can enhance customer experiences, especially in high-traffic venues like Disney World. Benioff also discusses the innovative integration of acquired technologies to drive growth.

31 snips
Mar 7, 2025 • 41min
Tariffs Tangle Markets, Businesses, Investors
Emily Flippen, a senior analyst at Motley Fool, delves into market trends and retail woes, revealing how shifting tariffs are creating economic uncertainty that even giants like Costco can't escape. Matt Argersinger analyzes the latest employment data and its impact on investor sentiment amidst rising inflation. Bestselling author Malcolm Gladwell reflects on the COVID response and shares insights from his new book, 'Revenge of the Tipping Point,' connecting societal changes to shifting economic landscapes.

21 snips
Mar 6, 2025 • 31min
Kroger CEO Kicked Out of Grocery Store
The discussion kicks off with Kroger's recent business performance while dodging the topic of its former CEO. Investors are growing cautious about Abercrombie & Fitch's future. A small-cap tobacco company is making waves in a booming market. The hosts then dive into revolutionary trends in robotic surgery, highlighting Intuitive Surgical's DaVinci System, which is changing how surgeries are performed. Insights on innovation, leadership, and strategic investments in robotics offer a glimpse into the future of medical technology.

20 snips
Mar 5, 2025 • 35min
Crypto's New Backer
Asit Sharma, an investment analyst at The Motley Fool, and Ricky Mulvey, another analyst specializing in cryptocurrency insights, dive into the growing intersection of finance and crypto. They discuss BlackRock's bold acquisition of ports and its implications for infrastructure investments. The conversation shifts to the captivating yet chaotic world of the ETH Denver conference, where they encounter the puzzling nature of new crypto technologies and the need for vigilant investing amidst excitement. A lively exploration of how policy shifts could reshape both traditional and digital investments ensues.

14 snips
Mar 4, 2025 • 31min
Tariffs Become Reality
Jason Moser, an investment analyst at The Motley Fool, dives into the recent 25% tariffs on goods from Canada and Mexico. He analyzes the implications for investors and companies, revealing how retailers like Target are adapting to market pressures. Moser also discusses Okta's potential in the security verification space, highlighting its revenue growth and strategic partnerships. Alongside Alison Southwick and Robert Brokamp, practical financial planning tips for solopreneurs are shared, emphasizing the importance of separating personal and business finances.

15 snips
Mar 3, 2025 • 30min
Now Serving: IPOs, Exits, Extra Cheese
Bill Barker, a Motley Fool analyst, dives into the excitement of Michu's IPO and its place alongside giants like Starbucks. He also discusses Kroger's CEO departure and its implications, plus the delightful introduction of stuffed crust pizza at Domino's. Joining him, Nick Sciple reveals the booming med spa industry, detailing how businesses are winning over clients with innovative aesthetic treatments and products like Evolus. The conversation blends food trends with investment insights, showcasing the dynamic market landscape.

31 snips
Mar 1, 2025 • 30min
The State of Weight-Loss Drugs
Karl Thiel, a Motley Fool analyst, dives deep into the booming weight-loss drug market projected to hit $150 billion. He unpacks the mechanics of GLP-1 medications like Ozempic and Mounjaro, detailing their differences and patent implications for investors. Thiel also discusses the economic ripple effects of these drugs, including shifts away from bariatric surgeries. Plus, get insights on undervalued companies and new drug developments that might change the weight-loss landscape forever.